JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act, regarding all provisions - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions - H.R. 3953 / S. 1874 Title VIII Nursing Workforce Reauthorization Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LEIF BRIERLEY | — |
| LARRY CAMM | — |
| MATTHEW CLARKIN | — |
| JULIA KALUSNIAK | — |
| DAVID KAVANAUGH | — |
| JEFFREY LAST | — |
| AMY PELLEGRINO | — |
| ABIGAIL PINKELE | — |
| MEGHAN DRENAN STONE | — |
| WENDY SUSSMAN | — |
| TIMOTHY SWOPE | — |
| COLLEEN VIVALDI | — |
| KELLY WATERS | — |
| FOLASHADE WILSON | — |
Budget/Appropriations BUD
- Issues related to stroke care
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIF BRIERLEY | — |
Copyright/Patent/Trademark CPT
- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act, regarding all provisions Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW CLARKIN | — |
| DAVID KAVANAUGH | — |
| WENDY SUSSMAN | — |
| TIMOTHY SWOPE | — |
Law Enforcement/Crime/Criminal Justice LAW
Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding, regarding all provisions - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding, regarding all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| KELLY WATERS | — |
Pharmacy PHA
- H.R. 2483, "SUPPORT for Patients and Communities Reauthorization Act of 2025", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY PELLEGRINO | — |
| WENDY SUSSMAN | — |
Science/Technology SCI
H.R.8413, the SECURE Data Act, regarding all provisions Issues related to - artificial intelligence - data privacy - cybersecurity - robotics
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIF BRIERLEY | — |
| MEGHAN DRENAN STONE | — |
Taxation/Internal Revenue Code TAX
Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax - S. 2003, the "Strengthening Benefits Plans Act", provisions on use of excess pension funds
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
| KELLY WATERS | — |
Veterans VET
Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIF BRIERLEY | — |
| MEGHAN DRENAN STONE | — |
| WENDY SUSSMAN | — |
| COLLEEN VIVALDI | — |
Trade (domestic/foreign) TRD
- Issues related to USMCA review and renegotiation
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIF BRIERLEY | — |
| DAVID KAVANAUGH | — |
| MEGHAN DRENAN STONE | — |
Defense DEF
- S.4784/H.R. 8800 National Defense Authorization Act (NDAA), regarding provision prohibiting Department of Defense (DOD) contracted companies from engaging in stock buybacks and issuing shareholder dividends absent a waiver from the Secretary
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LARRY CAMM | — |
| DAVID KAVANAUGH | — |
| COLLEEN VIVALDI | — |
| FOLASHADE WILSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.